Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × ensartinib × Thoracic × Clear all

Status

Not yet recruiting 6 Unknown 4 Recruiting 4 Completed 4 Active not recruiting 3 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

ulixertinib 1 telisotuzumab vedotin 1 epigallocatechin gallate 1 ensartinib 1 ceritinib 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04146571 2022-10-20

Expanded Access to Ensartinib for Participants With ALK+ NSCLC

Xcovery Holdings, Inc.

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡